Sermorelin & GHRP-6 Blend
A research blend of sermorelin and GHRP-6, combining GHRH-pathway stimulation with ghrelin-receptor activation and appetite-stimulating effects.
Community Rating
No ratings yet
⚠ Research & Educational Use Only. Sermorelin & GHRP-6 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Synergistic GH release via GHRH + ghrelin pathways
- GHRP-6 component promotes appetite stimulation
- Well-documented anabolic and recovery research profile
- Sermorelin & GHRP-6 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Synergistic GH release via GHRH + ghrelin pathways
- GHRP-6 component promotes appetite stimulation
- Well-documented anabolic and recovery research profile
- Additive GH pulse amplification vs single peptides
What is Sermorelin & GHRP-6 Blend?
Tap any underlined term for an instant definition.
Sermorelin & GHRP-6 Blend pairs the GHRH analogue sermorelin with GHRP-6, a ghrelin-mimetic GHS with pronounced appetite-stimulating effects via motilin receptor binding in addition to GHS-R1a. This combination is particularly studied in contexts where appetite stimulation alongside GH elevation is a desired research endpoint.
What It Is
- Sermorelin (GHRH 1-29): GHRH receptor agonist on pituitary somatotrophs
- GHRP-6: GHS-R1a agonist + motilin receptor partial agonist (producing appetite stimulation)
- GHRP-6 is historically the first GHRP developed; strong GH-releasing activity with motilin-mediated appetite effects
- Blend combines synergistic GH pathway stimulation
How It Works
- Same dual-receptor mechanism as sermorelin + GHRP-2
- GHRP-6 additionally binds motilin receptors in the GI tract, stimulating gastric motility and appetite
- GH pulse amplification: 3-4x either peptide alone
- The appetite effect of GHRP-6 can enhance caloric intake in research subjects, making this combination relevant for studying GH + nutrition interactions
Key Research Findings
- GH response: Similar amplitude to sermorelin + GHRP-2 in matched dose comparisons
- Appetite stimulation: Subjects reliably report increased hunger within 30-60 minutes of GHRP-6 injection
- Lean mass: Studies show comparable lean mass outcomes to sermorelin + ipamorelin when diet is controlled
Dosing From the Literature
- Sermorelin 200-300 mcg + GHRP-6 100-200 mcg per injection
- Once or twice daily
- Administer before expected meal if appetite stimulation is desired endpoint
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Sermorelin & GHRP-6 Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection. GHRP-6 stimulates appetite so timing before meals can be advantageous in bulking protocols.
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
- Tesamorelin & Ipamorelin Blend
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.